Paul Ross Fatheree

Title: Paul Ross Fatheree: Innovator in Respiratory Disease Treatment

Introduction:

In the realm of innovations and patents, there are individuals who leave remarkable contributions that shape industries and benefit society. One such innovator is Paul Ross Fatheree, a prolific inventor from San Francisco, CA (US). With an extensive portfolio of patents and a focus on respiratory disease treatment, Fatheree's work has made a significant impact in the medical field.

Latest Patents:

Paul Ross Fatheree's innovative spirit shines through his latest patents. In recent years, he has been involved in developing compounds that act as JAK kinase inhibitors, specifically targeting respiratory diseases. These patents include the following:

1. JAK kinase inhibitor compounds for the treatment of respiratory disease:

This patent focuses on compounds of formula (I) that demonstrate efficacy as JAK kinase inhibitors. These compounds, along with their pharmaceutical compositions, offer potential treatments for respiratory diseases. The invention also includes processes and intermediates for the preparation of these compounds.

2. Fused imidazo-piperidine JAK inhibitors:

The invention presented in this patent covers compounds of formula (I) as JAK kinase inhibitors, alongside their pharmaceutical compositions. These compounds exhibit potential for the treatment of respiratory diseases. The patent also provides details on the processes and intermediates utilized in their synthesis.

Career Highlights:

Throughout his career, Paul Ross Fatheree has contributed significantly to the field of respiratory disease treatment. Some of his notable career highlights include his association with Theravance, Inc. and Theravance Biopharma R&D IP, LLC. These companies are renowned for their dedication to pharmaceutical research and development in the respiratory and clinical field.

Collaborations:

Innovation often thrives in collaborative environments, and Fatheree's work has benefited from fruitful collaborations with fellow experts. Notably, he has worked alongside Seok-Ki Choi and Daniel Marquess, both of whom have made notable contributions in their respective fields. Collaborations of this nature encourage the exchange of ideas, leading to novel inventions and advancements.

Conclusion:

Paul Ross Fatheree's passion for innovation and dedication to respiratory disease treatment have resulted in a significant number of patents. His pioneering work in developing JAK kinase inhibitor compounds offers hope for improved treatments in the realm of respiratory diseases. With his career achievements and collaborations, Fatheree continues to make a remarkable impact in the field of medical inventions and patents.